Name: minimally-invasive technique for injection into rat optic nerve
Uploaded: 2015-05-19T14:00:00.000+00:00
Duration: 7 min 34 s
Description: Watch this Scientific Journal Video about Minimally-invasive Technique for Injection into Rat Optic Nerve at JoVE.com

This study was supported by NeuralStem, Inc., and Johns Hopkins Project RESTORE.

注：すべての動物の手順は、ジョンズ·ホプキンス大学動物実験委員会によって承認されました。麻酔機は、必要に応じて毎年点検とキャリブレーションが必要です。 1.麻酔とポジショニング<ol><li>麻酔。 <ol><li> 2〜3％のイソフルラン麻酔下で、すべての外科的処置を実行します。つま先のピンチと呼吸数による麻酔の適切なレベルを確認してください。ラットはつま先のピンチに反応して尻込みしていないことを確認してください。 注：フリンチは遅すぎる麻酔を示し、開始前に長い麻酔以上イソフルラン濃度を必要とする場合があります。 2秒ごとに麻酔を示す遅すぎる1息未満の呼吸率が高すぎて、イソフルラン濃度の軽量化が必要な場合があります。 </li><li>手順中にヘッドの移動を避けるために、必要に応じて動物を固定します。外科的な目にリドカインのドロップを置きます。麻酔下ながら乾燥を防止するために、人工涙液を10分ごとに使用します。与えます0.01ミリグラム/ kgのSC手術前にし、その後、6-8時間のブプレノルフィンの注射は、必要に応じて。 </li></ol></li><li>ポジショニング。 <ol><li>定位フレームにラットを配置し、加熱パッドで暖かく保ちます。目の露出を避けるために注意しながらアルコールと頭皮の毛をぬらし。術後感染症のリスクを最小限に抑えるために、滅菌ツールおよび滅菌技術を使用してください。 </li></ol></li></ol> 2. Eyeコントロール<ol><li>横結膜に4-0縫合糸を置き、穏やかなトラクションを可能にするのに十分な縫合糸でそれを結びます。 </li></ol> 3.解剖<ol><li>最初の解剖。 <ol><li> 図1に示すように、サイズ10メスを用いて軌道尾根の上を覆う皮膚中〜1インチの切開を行います。皮膚とその下の筋膜を引っ込め、慎重に筋膜を離れて解剖。外科的に過度の出血を防止するために、筋膜を切開しながら、血管を切断しないようにします。 PL戦略的に使用します止血を提供するために、綿のヒントを出し抜か。 </li></ol></li><li>深く解剖。 注：ダウンし、ソケットから目を引く結膜にやさしい牽引すると、優れた軌道筋肉が見えてきます。視神経を露出させるために、この筋肉を切断する必要があり、眼窩脂肪を除去しました。脂肪は破棄することができ、注入後に交換するべ​​きではありません。この点から、視神経筋膜は、硬膜に包まれた血管（ 図1）と一緒に、視神経自体の束として表示される必要があります。 <ol><li>低外傷性穿孔するためにメスまたは31ゲージベベル針を用いて硬膜内の小さな切開を行います。 </li></ol></li></ol> 4.ピペットインジェクタ<ol><li> 50〜100ミクロンの直径にガラスマイクロピペットを引き出します。安定性を提供するために、マイクロマニピュレータにマイクロピペットをマウントし、注入ポンプに接続されたハミルトンシリンジに接続します。 </li><li>ビーズを引き上げ（または幹細胞）前後のメチルブルー溶液0.5μlの体積と一緒に逆行マイクロピペットに0.5〜1.0μlのボリュームに再構成しました。 注：毎分0.5〜2μLに設定注入速度は、視神経への外傷を防ぐことができます。 </li></ol> 5.インジェクション<ol><li>ただ、ニックの入った硬膜上記視神経にマイクロピペットの先端を下げます。 注：少なくとも損傷で視神経結果にガラスチップの小さな、しかし、活発な動き。輸液ポンプが始まると、メチル青色色素を注入視神経の領域を強調表示する必要があります。色素はくも膜下腔に漏出することなく、視神経内に局在したまま必要があります。 </li><li>幹細胞の注入が完了すると判断し、メチルブルーの第二の用量が注入されるように注入ポンプをオフにするためにメチルブルーの第2帯域に従ってください。高い防ぐために注入し、それぞれ1μlのボリュームの2分間の視神経内にまだマイクロピペットを保ちますマイクロピペットの離脱時の圧力噴出。 注：別のアプローチは、手動で操作することができ、空気充填された注射器にピペットチップを接続することです。いずれにしても、視神経の損傷を最小限に抑えるために無理な力を避けます。私たちは、それぞれの視神経にボリュームのない2以下μLを注入することをお勧めします。 </li></ol> 6.フォローアップ<ol><li>即時。 <ol><li>注入が完了すると、止血を提供するために使用される任意の綿のヒントと一緒にマイクロピペットを削除します。 3-0シルクで皮膚を縫合し、結膜縫合糸を除去します。 </li><li>彼らは麻酔から出てくるまで、加熱パッド上に暖かいラットをしてください。それは胸骨横臥位を維持するのに十分な意識を取り戻したまで無人動物を放置しないでください。完全に回復するまで、他の動物の会社に手術を受けた動物を返しません。 </li><li>動物は、過度の嗜眠、運動失調、またはこじつけbreathin含む痛みの徴候を示している場合gであり、1日3回まで筋肉内ブプレノルフィン（0.05ミリグラム/ kg）で適切な鎮痛を管理します。 </li></ol></li><li>長期。 <ol><li>次の24〜48時間、腫れや放電傷から、またはそのような発声、猫背外観、非グルーミング、または食べていないような痛みの他の徴候を含む、手術の合併症のラットを観察します。必要に応じて獣医師や倫理的安楽死との協議を検討してください。 </li></ol></li></ol>

<ol>
	<li>Dahlmann-Noor, A., Vijay, S., Jayaram, H., Limb, A., Khaw, P. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Current+approaches+and+future+prospects+for+stem+cell+rescue+and+regeneration+of+the+retina+and+optic+nerve.">Current approaches and future prospects for stem cell rescue and regeneration of the retina and optic nerve.</a> Canadian journal of ophthalmology Journal canadien d'ophtalmologie. 45 (4), 333-341 (2010).</li><li>Quigley, H. A., Iglesia, D. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Stem+cells+to+replace+the+optic+nerve.">Stem cells to replace the optic nerve.</a> Eye. 18 (11), 1085-1088 (2004).</li><li>Ghaffarieh, A., Levin, L. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optic+nerve+disease+and+axon+pathophysiology.">Optic nerve disease and axon pathophysiology.</a> International review of neurobiology. 105, 1-17 (2012).</li><li>Fukui, Y., Hayasaka, S., Bedi, K. S., Ozaki, H. S., Takeuchi, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Quantitative+study+of+the+development+of+the+optic+nerve+in+rats+reared+in+the+dark+during+early+postnatal+life.">Quantitative study of the development of the optic nerve in rats reared in the dark during early postnatal life.</a> Journal of anatomy. 174, 37-47 (1991).</li><li>Celestre, P. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Minimally+invasive+approaches+to+the+cervical+spine.">Minimally invasive approaches to the cervical spine.</a> The Orthopedic clinics of North America. 43 (1), 137-147 (2012).</li><li>Hallas, B. H., Wells, M. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+Novel+Technique+for+Multiple+Injections+into+the+Mammalian+Optic+Nerve.">A Novel Technique for Multiple Injections into the Mammalian Optic Nerve.</a> Kopf Carrier. 54, (2001).</li><li>Harvey, A. R., Hellstrom, M., Rodger, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Gene+therapy+and+transplantation+in+the+retinofugal+pathway.">Gene therapy and transplantation in the retinofugal pathway.</a> Progress in brain research. 175, 151-161 (2009).</li><li>Adachi-Usami, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optic+neuritis--from+diagnosis+to+optic+nerve+transplantation.">Optic neuritis--from diagnosis to optic nerve transplantation.</a> Nippon Ganka Gakkai zasshi. 104 (12), 841-857 (2000).</li><li>Slater, B. J., Vilson, F. L., Guo, Y., Weinreich, D., Hwang, S., Bernstein, S. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optic+nerve+inflammation+and+demyelination+in+a+rodent+model+of+nonarteritic+anterior+ischemic+optic+neuropathy.">Optic nerve inflammation and demyelination in a rodent model of nonarteritic anterior ischemic optic neuropathy.</a> Investigative ophthalmology &amp; visual science. 54 (13), 7952-7961 (2013).</li><li>Zarbin, M. A., Arlow, T., Ritch, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Regenerative+nanomedicine+for+vision+restoration.">Regenerative nanomedicine for vision restoration.</a> Mayo Clinic proceedings. 88 (12), 1480-1490 (2013).</li></ol>

The authors have no meaningful disclosures to report.

Direct injection into the optic nerve of stem cells or other products intended to facilitate regeneration provides a convenient model compared to other means of injections into the CNS. This technique takes less time, requires less total anesthesia, avoids drilling or removing skull or bone tissue, reduces complications rates and allows for more rapid recovery following surgery. 
The most critical steps in this protocol include: 1. Adequate hemostasis in the surgical field to allow clear visualization of the optic nerve bundle, 2. Precise measurement of the pipette tip to allow easy insertion into the optic nerve with minimal trauma, 3. Tight control of eye using conjunctival suture which allows optimal exposure of the optic nerve. 
An alternative lateral approach to the optic nerve has been described previously which also allows injection directly into the optic nerve without dissection into the skull bone.6 In our experience, the lateral view is more limited to the very proximal optic nerve just behind the retina. In our superior approach, a larger portion of the optic nerve is visible allowing injection into both the proximal and mid-optic nerves. 
The major limitation of optic nerve injections is based on the rat&#8217;s limited use of vision. Rats can function well with their other senses of touch, hearing and smell and do not necessarily depend on vision as much as humans. Therefore, behavioral studies of rat vision have been limited to instinctual optokinetic reflexes and do not reliably correlate with an intact optic nerve. 
However, pathological assessments of axonal count and integrity, and myelination can provide useful information about the benefit of regenerative therapies. Furthermore, the pathological changes in the optic nerve are likely to represent changes in other parts of the CNS such as the brain and spinal cord that are more difficult to access. 
The most common current and future application of this procedure is for placement of regenerative stem cells into damage optic nerves. Various disorders of the optic nerve including trauma,7 inflammatory,8 and vascular9 etiologies can potentially benefit from regenerative strategies. Localized injections of small molecules and nanoparticles10 into the optic nerve are also being evaluated for regenerative potential.

視神経は、中枢神経系（CNS）は、視神経炎、緑内障および外傷などの眼科条件を含む再生研究のための理想的なロケーションを提供します。幹細胞の種々の注射は、いずれかの軸索の数を増加させ、および/ ​​または変性疾患を予防効果を示したか、失われたミエリンの取り付けの見込みを示している。1,2 人間の視神経が約3.0〜3.5ミリメートルの直径を有する視交叉に網膜から走行約120万平行軸索が含まれています。3、実験室でヒト疾患をモデル化するために、ラットは、頻繁に使用されています。成体ラットの視神経は、約0.5mmの直径内に約10万軸索を含んでいます。CNS再生研究の主な制限の4つは、直接骨なしアクセスです。頭蓋骨や脊椎骨が除去されたときに、動物に、合併症、手術リスクが高くなっています。の利点と同様に、頭蓋骨のオファー減少合併症、より迅速な回復を開かずに脊椎における低侵襲アプローチ、5直接視神経注射。 この技術は、以前の研究で使用されてきた。6本稿および付随ビデオでは、我々はラット視神経に幹細胞を注入するための低侵襲性の手順を示します。

<table><tbody><tr><td>Lewis rat</td><td>Charles River</td><td>4</td><td>Any rat strain will work.</td></tr><tr><td>Anesthesia machine</td><td>Surgivet</td><td>CDS9000</td><td>CDS 9000 Small Animal Anesthesia Machine - Pole Mount</td></tr><tr><td>Infusion pump</td><td>Stoelting</td><td>53129</td><td></td></tr><tr><td>Dissection microscope</td><td>National Optical</td><td>409-411-1105</td><td></td></tr><tr><td>Fiber-optic light source</td><td>Fisher Scientific</td><td>12-562-21</td><td></td></tr><tr><td>Dissection and Stereotaxic Instrument</td><td>Stoelting</td><td>51400</td><td></td></tr><tr><td>Pipette Puller</td><td>Kopf</td><td>750</td><td></td></tr><tr><td>Pipettes</td><td>World Precision Instruments</td><td>18150-6</td><td></td></tr><tr><td>Disposable scalpel blades</td><td>Harvard Apparatus</td><td>810-15-021</td><td></td></tr><tr><td>Iridectomy scissors</td><td>Electron Microscopy Sciences</td><td>Uniband LA-4XF</td><td></td></tr></tbody></table>

minimally-invasive technique for injection into rat optic nerve

The rat optic nerve is a useful model for stem cell regeneration research. Direct injection into the rat optic nerve allows delivery into the central nervous system in a minimally-invasive surgery without bone removal. This technique describes an approach to visualization and direct injection of the optic nerve following minor fascial dissection from the orbital ridge, using a conjunctival traction suture to gently pull the eye down and out. Representative examples of an injected optic nerve show successful injection of dyed beads.

実験の終わりに、ラットを屠殺し、4％パラホルムアルデヒドで灌流しました。視神経を注意深く切開し、クライオスタット切片のために取り付けられた2はエバンスブルー色素部位を可視化するために注入された低電力でラット全視神経の一例を示す図 。矢印は注射の正確な位置を特定します。神経ダウン色素の制限拡散によって示されるように、この切開は、注射の数分以内に行われました。他の注射では、数時間かけて視交叉に向けて染料の遅い拡散を観察しています。 <img alt="図1" src="/files/ftp_upload/52249/52249fig1highres.jpg" /> 図1：ビューの外科分野のラットは、この図では、左眼にアクセスするために配置されています。切開を軌道尾根と筋膜の上に作られて組織は、目の後ろにダウン解剖されます。結膜縫合糸は、オペレータが頭蓋骨を開くことなくビューに頭蓋内視神経を引く穏やかなトラクションを適用することができます。 <img alt="図2" src="/files/ftp_upload/52249/52249fig2highres.jpg" /> 図2：注入された視神経の総解剖エバンスブルー色素を利用するには、視神経における注射部位は、肉眼解剖顕微鏡下で可視化することができます。この画像では、視神経を視神経組織内に埋め込まれた染料を表示するために注射部位で切断しました。

Watch this Scientific Journal Video about Minimally-invasive Technique for Injection into Rat Optic Nerve at JoVE.com

Minimally-invasive Technique for Injection into Rat Optic Nerve

Direct injection into the rat optic nerve is useful for regenerative research. We demonstrate a minimally-invasive technique for direct injection into a rat optic nerve that does not involve opening the skull. Using this method, surgical complications are minimized and recovery is more rapid.

ラット視神経への注入のための低侵襲テクニック

The rat optic nerve is a useful model for stem cell regeneration research. Direct injection into the rat optic nerve allows delivery into the central ...

minimally-invasive-technique-for-injection-into-rat-optic-nerve

Universidad San Sebastian

Research

JoVE Journal

Neuroscience

9.5K ビュー.  Johns Hopkins University. Direct injection into the rat optic nerve is useful for regenerative research. We demonstrate a minimally-invasive technique for direct injection into a rat optic nerve that does not involve opening the skull. Using this method, surgical complications are minimized and recovery is more rapid. 

ビデオ: Minimally-invasive Technique for Injection into Rat Optic Nerve

Methods for Experimental Manipulations after Optic Nerve Transection in the Mammalian CNS

Retinal ganglion cells (RGCs) are CNS neurons that output visual information from the retina to the brain, via the optic nerve. The optic nerve can be accessed within the orbit of the eye and completely transected (axotomized), cutting the axons of the entire RGC population. Optic nerve transection is a reproducible model of apoptotic neuronal cell death in the adult CNS 1-4. This model is particularly attractive because the vitreous chamber of the eye acts as a capsule for drug delivery to the retina, permitting experimental manipulations via intraocular injections. The diffusion of chemicals through the vitreous fluid ensures that they act upon the entire RGC population. Viral vectors, plasmids or short interfering RNAs (siRNAs) can also be delivered to the vitreous chamber in order to infect or transfect retinal cells 5-12. The high tropism of Adeno-Associated Virus (AAV) vectors is beneficial to target RGCs, with an infection rate approaching 90% of cells near the injection site 6, 7, 13-15. Moreover, RGCs can be selectively transfected by applying siRNAs, plasmids, or viral vectors to the cut end of the optic nerve 16-19 or injecting vectors into their target the superior colliculus 10. This allows researchers to study apoptotic mechanisms in the injured neuronal population without confounding effects on other bystander neurons or surrounding glia. RGC apoptosis has a characteristic time-course whereby cell death is delayed 3-4 days postaxotomy, after which the cells rapidly degenerate. This provides a window for experimental manipulations directed against pathways involved in apoptosis. Manipulations that directly target RGCs from the transected optic nerve stump are performed at the time of axotomy, immediately after cutting the nerve. In contrast, when substances are delivered via an intraocular route, they can be injected prior to surgery or within the first 3 days after surgery, preceding the initiation of apoptosis in axotomized RGCs. In the present article, we demonstrate several methods for experimental manipulations after optic nerve transection.

Optic Nerve transection is a widely used model of adult CNS injury. This model is ideal for performing a number of experimental manipulations that target the retina globally or directly target the injured neuronal population of retinal ganglion cells.

哺乳類の中枢神経系における視神経切断後の実験操作のための方法

Retinal ganglion cells (RGCs) are CNS neurons that output visual information from the retina to the brain, via the optic nerve. The optic nerve can be ...

神経科学

Intravitreous Injection for Establishing Ocular Diseases Model

Intravitreous injection is a widely used technique in visual sciences research. It can be used to establish animal models with ocular diseases or as direct application of local treatment. This video introduces how to use simple and inexpensive tools to finish the intravitreous injection procedure. Use of a 1 ml syringe, instead of a hemilton syringe, is used. Practical tips for how to make appropriate injection needles using glass pipettes with perfect tips, and how to easily connect the syringe needle with the glass pipette tightly together, are given.
To conduct a good intravitreous injection, there are three aspects to be observed: 1) injection site should not disrupt retina structure; 2) bleeding should be avoided to reduce the risk of infection; 3) lens should be untouched to avoid traumatic cataract. In brief, the most important point is to reduce the interruption of normal ocular structure. To avoid interruption of retina, the superior nasal region of rat eye was chosen. Also, the puncture point of the needle was at the par planar, which was about 1.5 mm from the limbal region of the rat eye. A small amount of vitreous is gently pushed out through the puncture hole to reduce the intraocular pressure before injection. With the 45&deg; injection angle, it is less likely to cause traumatic cataract in the rat eye, thus avoiding related complications and influence from lenticular factors. In this operation, there was no cutting of the conjunctiva and ocular muscle, no bleeding. With quick and minor injury, a successful intravitreous injection can be done in minutes. 
The injection set outlined in this particular protocol is specific for intravitreous injection. However, the methods and materials presented here can also be used for other injection procedures in drug delivery to the brain, spinal cord or other organs in small mammals.

Intravitreous injection is a widely used technique in visual sciences research for ocular diseases or as direct application of local treatment. This video demonstrated a protocol for intravitreous injection using a 1ml syringe with glass pipette. Useful tips about avoiding massive bleeding and lens damage are given.

眼疾患モデルを確立するための硝子体内注射

Intravitreous injection is a widely used technique in visual sciences research. It can be used to establish animal models with ocular diseases or as ...

生物学

Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy

Posterior Ischemic optic neuropathy (PION) is a sight-devastating disease in clinical practice. However, its pathogenesis and natural history have&#160;remained poorly understood. Recently, we developed a reliable, reproducible animal model of PION and tested the treatment effect of some neurotrophic factors in this model1. The purpose of this video is to demonstrate our photochemically induced model of posterior ischemic optic neuropathy, and to evaluate its effects with retrograde labeling of retinal ganglion cells. Following surgical exposure of the posterior optic nerve, a photosensitizing dye, erythrosin B, is intravenously injected and a laser beam is focused onto the optic nerve surface. Photochemical interaction of erythrosin B and the laser during irradiation damages the vascular endothelium, prompting microvascular occlusion mediated by platelet thrombosis and edematous compression. The resulting ischemic injury yields a gradual but pronounced retinal ganglion cell dieback, owing to a loss of axonal input - a remote, injury-induced and clinically relevant outcome. Thus, this model provides a novel platform to study the pathophysiologic course of PION,&#160;and can be further optimized for testing therapeutic approaches for optic neuropathies as well as other CNS ischemic diseases.

The goal of this protocol is to photochemically induce ischemic injury to the posterior optic nerve in rat. This model is critical to studies of the pathophysiology of posterior ischemic optic neuropathy, and therapeutic approaches for this and other optic neuropathies, as well as of other CNS ischemic diseases.

光化学誘起後方虚血性視神経障害のラットモデル

Posterior Ischemic optic neuropathy (PION) is a sight-devastating disease in clinical practice. However, its pathogenesis and natural history ...

医学

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach

Subretinal injections have been successfully used in both humans and rodents to deliver therapeutic interventions of proteins, viral agents, and cells to the interphotoreceptor/subretinal compartment that has direct exposure to photoreceptors and the retinal pigment epithelium (RPE). Subretinal injections of plasminogen as well as recent preclinical and clinical trials have demonstrated safety and/or efficacy of delivering viral vectors and stem cells to individuals with advanced retinal disease. Mouse models of retinal disease, particularly hereditary retinal dystrophies, are essential for testing these therapies. The most common injection procedure in rodents is to use small transcorneal or transcleral incisions with an anterior approach to the retina. With this approach, the injection needle penetrates the neurosensory retina disrupting the underlying RPE and on insertion can easily nick the lens, causing lens opacification and impairment of noninvasive imaging. Accessing the subretinal space via a transcleral, posterior approach avoids these problems: the needle crosses the sclera approximately 0.5 mm from the optic nerve, without retinal penetration and avoids disrupting the vitreous. Collateral damage is limited to that associated with the focal sclerotomy and the effects of a transient, serous retinal detachment. The simplicity of the method minimizes ocular injury, ensures rapid retinal reattachment and recovery, and has a low failure rate. The minimal damage to the retina and RPE allows for clear assessment of the efficacy and direct effects of the therapeutic agents themselves. This manuscript describes a novel subretinal injection technique that can be used to target viral vectors, pharmacological agents, stem cells or induced pluripotent stem (iPS) cells to the subretinal space in mice with high efficacy, minimal damage, and fast recovery.

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach

Subretinal injections are the most common technique for delivering large therapeutic agents such as proteins and viral vectors to photoreceptors and the retinal pigment epithelium. An alternative method in mice that successfully targets the subretinal space with minimal collateral damage and fast recovery times is described here.

網膜下腔にアクセスするための代替と検証済みの注入方法<i&gt;経由で</i&gt;経強後方アプローチ

Subretinal injections have been successfully used in both humans and rodents to deliver therapeutic interventions of proteins, viral agents, and cells to ...

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rNAION)

Nonarteritic anterior ischemic optic neuropathy (NAION) is a focal ischemic lesion of the optic nerve that affects 1/700 individuals throughout their lifetime. NAION results in optic nerve edema, selective loss of the retinal ganglion cell neurons (RGCs) and atrophy of the optic nerve. A rodent model of NAION that expresses most NAION features and sequelae has been developed, which is applicable to both rats and mice. This model utilizes a focal laser application of 532 nm wavelength to illuminate a photoactive dye, Rose Bengal (RB), to cause capillary damage and leakage at the targeted anterior optic nerve (the laminar region). After rNAION induction, there is an early optic nerve ischemia, optic nerve edema, and intraneural inflammation, followed by selective RGC and axonal loss. Since the optic nerve is a CNS white matter tract, the rNAION model is applicable to mechanistic studies of selective white matter ischemia, as well as neuroprotective analyses and short and long-term mechanisms of glial and neuronal response to ischemia.

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION

The following report describes how to replicate the rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION), using the appropriate dye, contact lens and laser parameters. We also reveal the appropriate steps for evaluating the rNAION lesion in vivo.

Nonarteritic前部虚血性視神経症の齧歯類モデル（rNAION）

Nonarteritic anterior ischemic optic neuropathy (NAION) is a focal ischemic lesion of the optic nerve that affects 1/700 individuals throughout their ...

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

HR-SD-OCT is utilized to monitor the progression of photoreceptor degeneration in live mouse models, assess the delivery of therapeutic agents into the subretinal space, and to evaluate toxicity and efficacy in vivo. HR-SD-OCT uses near infrared light (800-880 nm) and has optics specifically designed for the unique optics of the mouse eye with sub-2-micron axial resolution. Transgenic mouse models of outer retinal (photoreceptor) degeneration and controls were imaged to assess the disease progression. Pulled glass microneedles were used to deliver sub retinal injections of adeno-associated virus (AAV) or nanoparticles (NP) via a trans-scleral and trans-choroidal approach. Careful positioning of the needle into the subretinal space was required prior to a calibrated pressure injection, which delivers fluid into the sub retinal space. Real time subretinal surgery was conducted on our retinal imaging system (RIS). HR-SD-OCT demonstrated progressive uniform retinal degeneration due to expression of a toxic mutant human mutant rhodopsin (P347S) (RHOP347S) transgene in mice. HR-SD-OCT allows rigorous quantification of all the retinal layers. Outer nuclear layer (ONL) thickness and photoreceptor outer segment length (OSL) measurements correlate with photoreceptor vitality, degeneration, or rescue. The RIS delivery system allows real-time visualization of subretinal injections in neonatal (~P10-14) or adult mice, and HR-SD-OCT immediately determines success of delivery and maps areal extent. HR-SD-OCT is a powerful tool that can evaluate the success of subretinal surgery in mice, in addition to measuring vitality of photoreceptors in vivo. HR-SD-OCT can also be used to identify uniform animal cohorts to evaluate the extent of retinal degeneration, toxicity, and therapeutic rescue in preclinical gene therapy research studies.

Here we demonstrate a novel approach to using high resolution spectral-domain optical coherence tomography (HR-SD-OCT) to assist delivery of gene therapy agents into the subretinal space, assess its areal coverage, and characterize photoreceptor vitality.

超高解像度マウス光コヒーレンストモグラフィー網膜遺伝子治療研究における眼内注入を支援するために

HR-SD-OCT is utilized to monitor the progression of photoreceptor degeneration in live mouse models, assess the delivery of therapeutic agents into the ...

Sheath-Preserving Optic Nerve Transection in Rats to Assess Axon Regeneration and Interventions Targeting the Retinal Ganglion Cell Axon

Retinal ganglion cell (RGC) axons converge at the optic nerve head to convey visual information from the retina to the brain. Pathologies such as glaucoma, trauma, and ischemic optic neuropathies injure RGC axons, disrupt transmission of visual stimuli, and cause vision loss. Animal models simulating RGC axon injury include optic nerve crush and transection paradigms. Each of these models has inherent advantages and disadvantages. An optic nerve crush is generally less severe than a transection and can be used to assay axon regeneration across the lesion site. However, differences in crush force and duration can affect tissue responses, resulting in variable reproducibility and lesion completeness. With optic nerve transection, there is a severe and reproducible injury that completely lesions all axons. However, transecting the optic nerve dramatically alters the blood brain barrier by violating the optic nerve sheath, exposing the optic nerve to the peripheral environment. Moreover, regeneration beyond a transection site cannot be assessed without reapposing the cut nerve ends. Furthermore, distinct degenerative changes and cellular pathways are activated by either a crush or transection injury.
The method described here incorporates the advantages of both optic nerve crush and transection models while mitigating the disadvantages. Hydrostatic pressure delivered into the optic nerve by microinjection completely transects the optic nerve while maintaining the integrity of the optic nerve sheath. The transected optic nerve ends are reapposed to allow for axon regeneration assays. A potential limitation of this method is the inability to visualize the complete transection, a potential source of variability. However, visual confirmation that the visible portion of the optic nerve has been transected is indicative of a complete optic nerve transection with 90-95% success. This method could be applied to assess axon regeneration promoting strategies in a transection model or investigate interventions that target the axonal compartments.

This protocol describes an optic nerve transection that preserves the optic nerve sheath in rats. Hydrostatic pressure from microinjections into the optic nerve generate a complete transection, allowing for sutureless reapposition of the transected optic nerve ends and direct targeting of the axonal compartment in a transection model.

Retinal ganglion cell (RGC) axons converge at the optic nerve head to convey visual information from the retina to the brain. Pathologies such as ...

Direct Vagus Nerve Injection Protocol For Rats

There is a relative abundance of strategies and methodologies to facilitate drug delivery to the central nervous system. However, drug delivery directly to the peripheral nervous system is less common, with fewer detailed methods publications available to aid researchers. Here, we describe a direct nerve injection method for peripheral nervous system drug delivery, using the vagus nerve as a model nerve. This method can be used in the treatment of autonomic nervous system disorders through targeting of the left vagus nerve, although this general injection method can be extrapolated to injection of other nerves with minor modification. This method explains all critical steps involved in the procedure involving microsurgery in anesthetized adult rats under a dissecting microscope. The use of a tracking dye is described to facilitate the monitoring of injection fidelity in real time. Illustrations of successful and failed injections are provided. If carried out properly, direct vagus nerve injections can be conducted in a safe manner that is well-tolerated by the rat without post-delivery complications. For example, once the surgeons were trained in this method, six out of six rats were successfully injected without any complications. This method of direct nerve injection for preclinical rat studies is capable of delivering agents (including but not limited to gene therapy) to peripheral nerves.

We present a protocol for direct vagus nerve injection in rats, enabling drug delivery directly into the nerve without post-injection complications. This method applies to preclinical neurological studies involving autonomic nervous system manipulation. It can be used for direct nerve injection for other nerves in rats and other species, with necessary modifications.

ラットのための直接迷走神経注射プロトコル

There is a relative abundance of strategies and methodologies to facilitate drug delivery to the central nervous system. However, drug delivery directly ...

Transconjunctival Approach for Injection into the Rat Optic Nerve

The rat serves as an important model for studying disorders of the optic nerve, including heritable, traumatic, neoplastic, and autoimmune conditions. Accessing the rat optic nerve for experimental manipulations and injections is challenging due to the small size of the orbit and the vascularity of the surrounding orbital tissues. Previous techniques have involved a cutaneous incision, which carries a higher risk of infection and requires wound closure. This study aims to describe a unique, less invasive, and potentially more efficient approach to accessing the rat optic nerve. A transconjunctival incision, along with a rat spinal cord hook, is used to isolate the optic nerve for experimental injections. In these experiments, an adenoviral vector is injected into the optic nerve with the goal of using this technique for direct gene therapy delivery in the future. This technique can also be applied by investigators requiring access to the rat optic nerve for other experimental studies, including drug delivery and optic nerve injury research.

This protocol describes a unique technique using a transconjunctival approach to access the rat optic nerve for injections.

ラット視神経への注射のための経結膜アプローチ

The rat serves as an important model for studying disorders of the optic nerve, including heritable, traumatic, neoplastic, and autoimmune conditions. ...

<meta charset="utf8"></head><body>組織損傷を軽減するための最適化されたラット内皮内注射技術

Intracameral Injection in Rats with Low Risk of Adverse Effects

Intracameral injection is a standard administration routine in ophthalmology. The application of intracameral injection in rodents for research is challenging due to the limiting dimensions and anatomy of the eye, including the small aqueous humor volume, the lens curvature, and lens thickness. Potential damage during intracameral injections introduces adverse effects and experimental variability. This protocol describes a procedure for intracameral injection in rats, allowing precision and reproducibility.
Sprague-Dawley rats were used as experimental models. Since the lens position in rats protrudes into the anterior chamber, injecting from the periphery, as done in humans, is unfavorable. Therefore, an incision is created in the central corneal region using a 31 gauge 0.8 mm stiletto blade to form a self-sealing tunnel into the anterior chamber. An incision at&#160;an angle close to the flat allows to create a long tunnel, which minimizes the loss of aqueous humor and shallowing of the anterior chamber. A 34 gauge nanoneedle is inserted into the tunnel for injection. This enables penetration with minimal friction resistance and avoids touching the lens. Injection of trypan-blue allows&#160;visualization&#160;by slit microscopy the presence of the dye in the anterior chamber and exclude leakage. Bioavailability to the corneal endothelial layer is demonstrated by injection of Hoechst dye, which stained the nuclei of corneal endothelial cells after injection.
In conclusion, this protocol implements a procedure for accurate intracameral injection in rats. This procedure may be used for intracameral delivery of various drugs and compounds in experimental rat models, increasing the efficiency and reproducibility of ophthalmic research.

<meta charset="utf8"></head><body>著者スポットライト:げっ歯類眼科における精度を高めるための皮内皮内注射の新しいプロトコル

This protocol describes a technique for intracameral injection in rats using a central corneal incision and a long tunnel into the anterior chamber. This injection method minimizes the risk of inducing inadvertent tissue damage and thereby improves precision and reproducibility.

ラット視神経への注入のための低侵襲テクニック

要約

さらに動画を探す

この動画の章